Publication | Open Access
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
35
Citations
20
References
2023
Year
Survival OutcomesOncologyHepatologyPathologyBevacizumab Versus LenvatinibLiver CancerMedicineRadiation OncologyHepatocellular Carcinoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1